BENZTROPINE MESYLATE
- Product NDC
- 72162-2596
- Requested package NDC
- 72162-2596-2
- 11-digit product format
- 721622596
- Labeler code
- 72162
- Product ID
- 72162-2596_959a0659-677c-4d0d-a77d-bf41abd0cebc
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- BENZTROPINE MESYLATE
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA212694
- Marketing category
- ANDA
- Marketing start
- 2025-08-11
- Substance
- BENZTROPINE MESYLATE
- Active strength
- 2 mg/1
- Pharmacologic classes
- Anticholinergic [EPC], Antihistamine [EPC], Cholinergic Antagonists [MoA], Histamine Receptor Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A212694-001 | BENZTROPINE MESYLATE | BENZTROPINE MESYLATE | 0.5MG | TABLET / ORAL | AA | 2025-02-11 | |
| A212694-002 | BENZTROPINE MESYLATE | BENZTROPINE MESYLATE | 1MG | TABLET / ORAL | AA | 2025-02-11 | |
| A212694-003 | BENZTROPINE MESYLATE | BENZTROPINE MESYLATE | 2MG | TABLET / ORAL | AA | 2025-02-11 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A212694-001 | AA |
| A212694-002 | AA |
| A212694-003 | AA |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A212694-001 | BENZTROPINE MESYLATE | 0.5MG | TABLET / ORAL | AA | 2025-02-11 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A212694-002 | BENZTROPINE MESYLATE | 1MG | TABLET / ORAL | AA | 2025-02-11 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A212694-003 | BENZTROPINE MESYLATE | 2MG | TABLET / ORAL | AA | 2025-02-11 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A212694-001 | BENZTROPINE MESYLATE | 0.5MG | TABLET / ORAL | AA | 2025-02-11 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A212694-002 | BENZTROPINE MESYLATE | 1MG | TABLET / ORAL | AA | 2025-02-11 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A212694-003 | BENZTROPINE MESYLATE | 2MG | TABLET / ORAL | AA | 2025-02-11 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A212694-001 | BENZTROPINE MESYLATE | 0.5MG | TABLET / ORAL | AA | 2025-02-11 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A212694-002 | BENZTROPINE MESYLATE | 1MG | TABLET / ORAL | AA | 2025-02-11 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A212694-003 | BENZTROPINE MESYLATE | 2MG | TABLET / ORAL | AA | 2025-02-11 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A212694-001 | BENZTROPINE MESYLATE | 0.5MG | TABLET / ORAL | AA | 2025-02-11 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A212694-002 | BENZTROPINE MESYLATE | 1MG | TABLET / ORAL | AA | 2025-02-11 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A212694-003 | BENZTROPINE MESYLATE | 2MG | TABLET / ORAL | AA | 2025-02-11 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A212694-001 | BENZTROPINE MESYLATE | 0.5MG | TABLET / ORAL | AA | 2025-02-11 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A212694-002 | BENZTROPINE MESYLATE | 1MG | TABLET / ORAL | AA | 2025-02-11 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A212694-003 | BENZTROPINE MESYLATE | 2MG | TABLET / ORAL | AA | 2025-02-11 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A212694-001 | BENZTROPINE MESYLATE | 0.5MG | TABLET / ORAL | AA | 2025-02-11 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A212694-002 | BENZTROPINE MESYLATE | 1MG | TABLET / ORAL | AA | 2025-02-11 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A212694-003 | BENZTROPINE MESYLATE | 2MG | TABLET / ORAL | AA | 2025-02-11 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A212694-001 | BENZTROPINE MESYLATE | 0.5MG | TABLET / ORAL | AA | 2025-02-11 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A212694-002 | BENZTROPINE MESYLATE | 1MG | TABLET / ORAL | AA | 2025-02-11 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A212694-003 | BENZTROPINE MESYLATE | 2MG | TABLET / ORAL | AA | 2025-02-11 | b8a1b40f171c… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A212694-001 | BENZTROPINE MESYLATE | 0.5MG | TABLET / ORAL | AA | 2025-02-11 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A212694-002 | BENZTROPINE MESYLATE | 1MG | TABLET / ORAL | AA | 2025-02-11 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A212694-003 | BENZTROPINE MESYLATE | 2MG | TABLET / ORAL | AA | 2025-02-11 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A212694-001 | AA | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A212694-002 | AA | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A212694-003 | AA | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A212694-001 | AA | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A212694-002 | AA | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A212694-003 | AA | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A212694-001 | AA | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A212694-002 | AA | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A212694-003 | AA | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A212694-001 | AA | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A212694-002 | AA | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A212694-003 | AA | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A212694-001 | AA | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A212694-002 | AA | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A212694-003 | AA | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A212694-001 | AA | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A212694-002 | AA | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A212694-003 | AA | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A212694-001 | AA | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A212694-002 | AA | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A212694-003 | AA | 1 | b8a1b40f171c… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A212694-001 | AA | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A212694-002 | AA | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A212694-003 | AA | 1 | a50c72e98297… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- BENZTROPINE MESYLATE
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| BENZTROPINE MESYLATE | 2 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| WMJ8TL7510 | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 885209 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 284e78af-7544-4c4a-8081-74e45501dc76 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 2961cf47-535c-c402-c24d-0a9130269674 | Product name | 3 | 20251121 |
| 3f930a8b-cc65-fba9-e4ca-58b6abcea16b | Product name | 2 | 20220509 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72162-2596-0 | BENZTROPINE MESYLATE | 1000 in 1 BOTTLE | TABLET | 1000 | 100 | |
| 72162-2596-1 | BENZTROPINE MESYLATE | 100 in 1 BOTTLE | TABLET | 100 | 100 | |
| 72162-2596-2 | BENZTROPINE MESYLATE | 100 in 1 BOTTLE | TABLET | 100 | 100 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 72162-2596-0 | EA - Each | 72162-2596 | eb40daa9-9716-4c53-8152-5d9506a599cc | 1 | 2026-02-05 |
| 72162-2596-1 | EA - Each | 72162-2596 | 9c16dce1-ada9-42c9-90e2-3a9f3ea0c04d | 1 | 2026-02-05 |
| 72162-2596-2 | EA - Each | 72162-2596 | f5fc34a6-6a8f-47d0-b966-030edb53019e | 1 | 2026-02-05 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| BENZTROPINE MESYLATE | BENZTROPINE MESYLATE | Bryant Ranch Prepack | ae749a71-d253-474d-a26c-bec780c5b09c | 2026-02-16 | Warnings, Adverse reactions | 212694 ANDA212694 |
| BENZTROPINE MESYLATE | BENZTROPINE MESYLATE | Bryant Ranch Prepack | 9270d14c-b885-4679-8871-6f2547450398 | 2026-01-07 | Warnings, Adverse reactions | 212694 ANDA212694 |
| BENZTROPINE MESYLATE | BENZTROPINE MESYLATE | Bryant Ranch Prepack | 284e78af-7544-4c4a-8081-74e45501dc76 | 2026-01-07 | Warnings, Adverse reactions | 212694 ANDA212694 72162-2596-2 72162-2596 72162259602 |
| BENZTROPINE MESYLATE | BENZTROPINE MESYLATE | QUAGEN PHARMACEUTICALS LLC | e1f0a249-e660-4592-9ffc-1c02b1022778 | 2025-06-17 | Warnings, Adverse reactions | 212694 ANDA212694 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 885209 | benztropine mesylate 2 MG Oral Tablet | PSN | 284e78af-7544-4c4a-8081-74e45501dc76 | 100 |
| 885209 | benztropine mesylate 2 MG Oral Tablet | SCD | 284e78af-7544-4c4a-8081-74e45501dc76 | 100 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 72162-2596-2 | 72162259602 | 100 TABLET in 1 BOTTLE (72162-2596-2) | 100 tablet | 2026-01-07 | No | No | Current |